Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-072560
Filing Date
2025-05-15
Accepted
2025-05-15 16:04:22
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-20250331.htm   iXBRL 10-Q 2467295
2 EX-31.1 sldb-ex31_1.htm EX-31.1 16622
3 EX-31.2 sldb-ex31_2.htm EX-31.2 16593
4 EX-32.1 sldb-ex32_1.htm EX-32.1 10254
5 EX-32.2 sldb-ex32_2.htm EX-32.2 10237
6 GRAPHIC img247593112_0.jpg GRAPHIC 1163815
  Complete submission text file 0000950170-25-072560.txt   11935742

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sldb-20250331.xsd EX-101.SCH 1411457
70 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20250331_htm.xml XML 1458692
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 25952567
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)